​

Diapin was founded by Dr. Yuqing (Eugene) Chen, M.D., Ph.D., based on technology from the University of Michigan from Dr. Chen’s laboratory. Diapin Therapeutics is a spin out company from the University of Michigan. Research at Diapin has been funded by grants, Beijing SL Pharmaceuticals LTD (Beijing SL), and private investors. (See Investors and Collaborators).​

​